Episode
Leadership Insights into Pipeline Strategy with Emily Roberts-Thomson, Raj Patel, Nikhil Dube, and Mukhtar Ahmed
- Published
- Jan 22, 2026
- Duration seconds
- 1562
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-cog-review-building-better-clinical-studies-7614513/episodes/leadership-insights-into-pipeline-strategy-with-emily-roberts-thomson-raj-patel-nikhil-dube-and-mukhtar-ahmed/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-cog-review-building-better-clinical-studies-7614513/leadership-insights-into-pipeline-strategy-with-emily-roberts-thomson-raj-patel-nikhil-dube-and-mukhtar-ahmed.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Pipeline Strategy: Balancing Science, Feasibility, and ROI in Clinical Development Decisions What does it take to make confident, cross-functional pipeline decisions that drive approval speed and sustainable value for companies in today’s clinical research landscape? Moderated by Emily Roberts-Thomson, Development Operations Leader Featuring: • Raj Patel, Chief Operating Officer, ReacX Pharmaceuticals • Nikhil Dube, Lifecycle Management Strategy Lead, Biogen • Mukhtar Ahmed, Director, Project and Portfolio Strategy, Greenstone Biosciences Recorded live at COG Bay Area, this panel brings together senior voices from leading biotech and pharma organizations to tackle the realities of pipeline prioritization and clinical operations best practices. Moderated by Emily Roberts-Thomson, the discussion centers on actionable frameworks and leadership judgment required for effective clinical trial outsourcing, CRO selection, and cross-functional portfolio management. The panelists break down how organizations decide which programs to advance, weighing scientific potential against development feasibility, market factors, risk, and resource constraints. They candidly explore trade-offs inherent to outsourcing strategies, clinical study optimization, and how changes in ROI, timelines, or operational setbacks impact pipeline decisions. Essential listening for clinical operations leaders, outsourcing specialists, and study owners, the episode delivers practical insights on moving from scientific conviction to commercial success—and ensuring alignment across sponsors, CRO partners, and governance bodies in a rapidly shifting environment for clinical trial outsourcing. Key topics include: Balancing science, feasibility, and business drivers in pipeline advancement decisions Managing cro…